These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29299369)

  • 21. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients.
    Teyateeti A; Mahvash A; Long JP; Abdelsalam ME; Avritscher R; Chasen B; Kaseb AO; Kuban JD; Murthy R; Odisio BC; Teyateeti A; Macapinlac HA; Kappadath SC
    J Hepatocell Carcinoma; 2020; 7():117-131. PubMed ID: 32984089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study.
    Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH
    Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Trans-Arterial Yttrium-90 Radioembolization in Patients with Unresectable Liver-Dominant Metastatic or Primary Hepatic Soft Tissue Sarcomas.
    Testa S; Bui NQ; Wang DS; Louie JD; Sze DY; Ganjoo KN
    Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study.
    Kayaleh R; Krzyston H; Rishi A; Naziri J; Frakes J; Choi J; El-Haddad G; Parikh N; Sweeney J; Kis B
    J Vasc Interv Radiol; 2020 Jul; 31(7):1060-1068. PubMed ID: 32534978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combining Transarterial Radioembolization (TARE) and CT-Guided High-Dose-Rate Interstitial Brachytherapy (CT-HDRBT): A Retrospective Analysis of Advanced Primary and Secondary Liver Tumor Treatment.
    Fleckenstein FN; Roesel MJ; Krajewska M; Auer TA; Collettini F; Maleitzke T; Böning G; Torsello GF; Fehrenbach U; Gebauer B
    Cancers (Basel); 2021 Dec; 14(1):. PubMed ID: 35008236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
    Wu X; Heller M; Lokken RP; Fidelman N; Lam A
    J Vasc Interv Radiol; 2023 May; 34(5):815-823.e1. PubMed ID: 36693521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of radiation dose to efficacy of radioembolization of liver metastasis from breast cancer.
    Ridouani F; Soliman MM; England RW; Hsu M; Moskowitz CS; Doustaly R; Sofocleous CT; Boas FE; Yarmohammadi H; Deipolyi AR
    Eur J Radiol; 2021 Mar; 136():109539. PubMed ID: 33476965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor: Transarterial Chemoembolization versus Transarterial Radioembolization.
    Currie BM; Nadolski G; Mondschein J; Dagli M; Sudheendra D; Stavropoulos SW; Soulen MC
    J Vasc Interv Radiol; 2020 Oct; 31(10):1627-1635. PubMed ID: 33004146
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization.
    Köhler M; Harders F; Lohöfer F; Paprottka PM; Schaarschmidt BM; Theysohn J; Herrmann K; Heindel W; Schmidt HH; Pascher A; Stegger L; Rahbar K; Wildgruber M
    J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31881761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of Radioembolization in the Management of Liver-Dominant Metastatic Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Bibok A; Mhaskar R; Jain R; Zhang J; Frakes J; Hoffe S; El-Haddad G; Parikh N; Ahmed A; Fishman MN; Choi J; Kis B
    Cardiovasc Intervent Radiol; 2021 Nov; 44(11):1755-1762. PubMed ID: 34312688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma-An Evaluation of Predictors.
    Paprottka KJ; Galiè F; Ingrisch M; Geith T; Ilhan H; Todica A; Michl M; Nadjiri J; Paprottka PM
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C; Lazarev S; Ru M; Kim E; Fischman A; Moshier E; Rosenzweig K; Buckstein M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):968-976. PubMed ID: 31536781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transarterial radioembolization with Iodine-131-Lipiodol for hepatic metastases from gastrointestinal malignancies - Experience in tertiary care oncology center in India.
    Bhargavi V; Subbanna I; Kallur KG; Patel A; Swamy S; Patil S
    South Asian J Cancer; 2019; 8(1):31-34. PubMed ID: 30766849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
    Kallini JR; Gabr A; Salem R; Lewandowski RJ
    Adv Ther; 2016 May; 33(5):699-714. PubMed ID: 27039186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.
    White J; Carolan-Rees G; Dale M; Patrick HE; See TC; Bell JK; Manas DM; Crellin A; Slevin NJ; Sharma RA
    J Vasc Interv Radiol; 2019 Aug; 30(8):1185-1192. PubMed ID: 31255499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transarterial radioembolization with yttrium-90 of unresectable primary hepatic malignancy in children.
    Aguado A; Ristagno R; Towbin AJ; Gupta A; Haberle S; Qi Z; Patel MN; Kukreja KU; Tiao GM; Geller JI
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27510. PubMed ID: 30406959
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association Between Curative Treatment after Transarterial Radioembolization and Better Survival Outcomes in Patients with Hepatocellular Carcinoma.
    Kim Y; Lee HA; Lee JS; Jeon MY; Kim BK; Park JY; Kim DY; Ahn SH; Um SH; Seo YS; Kim SU
    Cancer Invest; 2021 Mar; 39(3):274-283. PubMed ID: 33356630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pooled analysis of transarterial radioembolization with yttrium-90 microspheres for the treatment of unresectable intrahepatic cholangiocarcinoma.
    Zhen Y; Liu B; Chang Z; Ren H; Liu Z; Zheng J
    Onco Targets Ther; 2019; 12():4489-4498. PubMed ID: 31239717
    [No Abstract]   [Full Text] [Related]  

  • 39. Yttrium-90 Radioembolization of Advanced, Unresectable Breast Cancer Liver Metastases-A Single-Center Experience.
    Pieper CC; Meyer C; Wilhelm KE; Block W; Nadal J; Ahmadzadehfar H; Willinek WA; Schild HH
    J Vasc Interv Radiol; 2016 Sep; 27(9):1305-1315. PubMed ID: 27461588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers associated with survival and favourable outcome of radioembolization with yttrium-90 glass microspheres for colon cancer liver metastases: Single centre experience.
    Triviño-Ibáñez EM; Pardo Moreno P; Ciampi Dopazo JJ; Ramos-Font C; Ruiz Villaverde G; González-Flores E; Navarro Vergara PF; Rashki M; Gómez-Río M; Rodríguez-Fernández A
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021 Jul; ():. PubMed ID: 34294586
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.